AtlasXomics is a biotechnology company accelerating spatial multi-omics for application in oncology, neurology, and aging.
AtlasXomics has raised $3.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2022.
AtlasXomics is headquartered in New Haven, United States.
AtlasXomics is a biotechnology company accelerating spatial multi-omics for application in oncology, neurology, and aging.
AtlasXomics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AtlasXomics — Funding & Investors." VCBacked, January 6, 2022, https://www.vcbacked.co/company/atlasxomics. Accessed August 14, 2026.
VCBacked. (2022). AtlasXomics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/atlasxomics
{{cite web |title=AtlasXomics — Funding & Investors |url=https://www.vcbacked.co/company/atlasxomics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated